Syngene shares surged despite a 19% YoY decline in Q4FY26 net profit to Rs 148 crore, as earnings rebounded sharply from Rs 15 crore in the...

Biocon shares: The board approved a hike in the company’s authorised share capital from Rs 625 crore to Rs 700 crore, along with a correspo...

The company reported a net profit (before exceptional items) of Rs 1533 crore in the September 2024 quarter, compared with Rs 1,017 crore i...

Shares of ZEEL, JSW Steel, Godrej Industries, Glaxo and Sobha will be in focus as the companies will announce their quarterly results.

Ashok Leyland's Q4 net sales are expected to increase by 35% YoY to Rs 11,786 crore, with net profit likely to decline 10% to Rs 807 crore....

Total revenues rose 23% YoY for Q2FY23 at Rs 2,384 crore compared to Rs 1,945 crore in Q2FY22

The earnings before interest, tax depreciation and amortisation (EBITDA) rose 25% YoY to Rs 537 crore. The EBITDA margins for the third qua...

Banks were among the top drivers of the rally, with ICICI Bank rallying 5% and SBI 3.5%.

Deepak Nitrite profits were up by around 178%. EBITDA margins jumped to 23-24%.

The stock price has priced in all the near-term positives arising from the business — leaving little room for any risks.

"Biocon's product line up has been the result of investments of about Rs 250-300 crore that they had done about three years ago."

I would definitely put my bet on Biocon because clearly the management indicated that R&D expense was one of the key reasons lower margins,...

"The company's numbers have been lower than expectations. The positivity, however, has been that global crude oil prices, which is their co...

'The earnings season and the talk by the FED to taper should possibly keep the market a little bit suppressed.'

"The biggest problem is that investors do not want us to spend on R&D and R&D is a very integral part of our business."

Gaurang Shah, AVP, Geojit BNP Paribas to ET Now on Ranbaxy stocks.

Religare Research has maintained a ‘buy’ on Biocon post its second quarter earnings for the September quarter. It has set a target price of...